Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis

Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis

Voriconazole is one of the most used antifungal azoles against pulmonary aspergillosis. Therapeutic drug monitoring (TDM) of the voriconazole concentration in plasma is recommended in clinical practice guidelines to prevent treatment failure and toxicity. The aim of this study was to evaluate the fe...

Full description

Bibliographic Details
Main Authors:	Sacha Sarfati, Julien Wils, Timothée Lambert, Céline Mory, Laurent Imbert, Gilles Gargala, Hélène Morisse-Pradier, Fabien Lamoureux
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Pharmaceutics
Subjects:	therapeutic drug monitoring voriconazole sputum trough concentration pulmonary aspergillosis
Online Access:	https://www.mdpi.com/1999-4923/14/8/1598

Similar Items

Voriconazole-Induced Hepatotoxicity in a Patient with Pulmonary Aspergillosis: A Case Report
by: Gu L, et al.
Published: (2023-08-01)

Orbital Aspergillosis: Voriconazole – The New Standard Treatment
by: Derek H. Ohlstein, et al.
Published: (2012-02-01)

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
by: Grau S, et al.
Published: (2016-12-01)

Successful treatment of multiple intracerebral aspergillosis with voriconazole alone in an Egyptian diabetic patient with autoimmune hemolytic anemia
by: Hamdy Ibrahim, et al.
Published: (2023-10-01)

Invasive aspergillosis: Is treatment with "inexpensive" amphotericin B cost saving if "expensive" voriconazole is only used on demand?
by: G Schnetzler, et al.
Published: (2006-10-01)

Rechallenge of voriconazole successfully tolerated after hepatic toxicity
by: O. Narumoto, et al.
Published: (2020-01-01)

Sputum Galactomannan Has Utility in the Diagnosis of Chronic Pulmonary Aspergillosis
by: Ali Nuh, et al.
Published: (2022-02-01)

Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention
by: Ranjot Kaur, et al.
Published: (2021-01-01)

Hyperlipidemia Caused by Voriconazole: A Case Report
by: Wu J, et al.
Published: (2021-02-01)

Invasive aspergillosis: results of multicenter study
by: N. N. Klimko, et al.
Published: (2014-09-01)

Invasive aspergillosis: results of multicenter study
by: N. N. Klimko, et al.
Published: (2014-09-01)

Efficacy and safety of voriconazole in the treatment of invasive pulmonary aspergillosis in patients with liver failure: study protocol for a randomized controlled clinical trial
by: Xue Yu, et al.
Published: (2023-12-01)

Invasive aspergillosis of tympanomastoid cavity
by: Santosh Kumar Swain, et al.
Published: (2019-01-01)

Renal aspergillosis after COVID‐19‐associated pulmonary aspergillosis: A case report
by: Roya Ghasemian, et al.
Published: (2023-09-01)

Intracranial abscess due to disseminated aspergillosis in a renal transplant recipient - A case report
by: Sashi Kiran Annavarajula, et al.
Published: (2021-01-01)

Chronic pulmonary aspergillosis - case series and review of Indian literature
by: Vikas Marwah, et al.
Published: (2021-01-01)

Treatment of Aspergillosis
by: Jeffrey D. Jenks, et al.
Published: (2018-08-01)

A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model
by: Taotao Wang, et al.
Published: (2018-06-01)

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence
by: Ethan R. Stewart, et al.
Published: (2016-09-01)

Enhancing voriconazole therapy in liver dysfunction: exploring administration schemes and predictive factors for trough concentration and efficacy
by: Yichang Zhao, et al.
Published: (2024-01-01)

Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave
by: Robbert G. Bentvelsen, et al.
Published: (2022-01-01)

Management of pulmonary aspergillosis in children: a systematic review
by: Vito Terlizzi, et al.
Published: (2023-03-01)

Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes
by: Baddley John W, et al.
Published: (2013-01-01)

Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
by: Milo Gatti, et al.
Published: (2023-04-01)

Pharmacoeconomic evaluation of isavuconazole, posaconazole, and voriconazole for the treatment of invasive mold diseases in hematological patients: initial therapy prior to pathogen differential diagnosis in China
by: Guangxin Han, et al.
Published: (2023-12-01)

A Large Sample Retrospective Study on the Distinction of Voriconazole Concentration in Asian Patients from Different Clinical Departments
by: Yichang Zhao, et al.
Published: (2021-11-01)

Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
by: V. I. Ignatieva, et al.
Published: (2015-06-01)

Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
by: V. I. Ignatieva, et al.
Published: (2015-06-01)

Favorable Effects of Voriconazole Trough Concentrations Exceeding 1 μg/mL on Treatment Success and All-Cause Mortality: A Systematic Review and Meta-Analysis
by: Yuki Hanai, et al.
Published: (2021-04-01)

Spinal aspergillosis: a rare clinical case and a review of the literature
by: Denis G. Naumov, et al.
Published: (2023-06-01)

Fatal invasive aspergillosis caused by Aspergillus niger after bilateral lung transplantation
by: Enora Atchade, et al.
Published: (2017-09-01)

A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease
by: Eisuke Mochizuki, et al.
Published: (2015-01-01)

Clinical Risk Score for Invasive Pulmonary Aspergillosis in Patients With Liver Failure: A Retrospective Study in Zhejiang
by: Xuan Zhang, et al.
Published: (2021-11-01)

A suspected case of autoinduction of voriconazole metabolism in a patient with cerebral aspergillosis
by: Ferguson MJ, et al.
Published: (2017-09-01)

Successful treatment of cerebral aspergillosis: case report of a patient with T-cell large granular lymphocytic leukemia (T-LGL)
by: Amin T. Turki, et al.
Published: (2017-12-01)

Frequency of Pulmonary Aspergillosis Among Clinically Suspected and Under Treatment Tuberculosis Patients , Khartoum State , Sudan
by: Abubaker Agbash Baraka, et al.
Published: (2021-12-01)

Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags
by: Andréa I.H. Adams, et al.

Survival in a pediatric patient with cerebral aspergillosis: A case report
by: Ana Paula Ramírez-Acosta, et al.
Published: (2024-01-01)

Sputum induction in the diagnosis of pulmonary tuberculosis in patients without sputum
by: Safavi E, et al.
Published: (2011-04-01)

To compare the safety and efficacy of intrastromal voriconazole alone and in combination with intracameral voriconazole in intractable cases of fungal keratitis
by: Monika Dahiya, et al.
Published: (2023-08-01)